HK1211574A1 - 絲氨酸/蘇氨酸激酶抑制劑 - Google Patents
絲氨酸/蘇氨酸激酶抑制劑Info
- Publication number
- HK1211574A1 HK1211574A1 HK15112240.6A HK15112240A HK1211574A1 HK 1211574 A1 HK1211574 A1 HK 1211574A1 HK 15112240 A HK15112240 A HK 15112240A HK 1211574 A1 HK1211574 A1 HK 1211574A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- kinase inhibitors
- threonine kinase
- serine threonine
- serine
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261714558P | 2012-10-16 | 2012-10-16 | |
| PCT/EP2013/071496 WO2014060395A1 (en) | 2012-10-16 | 2013-10-15 | Serine/threonine kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1211574A1 true HK1211574A1 (zh) | 2016-05-27 |
Family
ID=49354684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15112240.6A HK1211574A1 (zh) | 2012-10-16 | 2015-12-11 | 絲氨酸/蘇氨酸激酶抑制劑 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9382257B2 (zh) |
| EP (1) | EP2909206A1 (zh) |
| JP (1) | JP2015533151A (zh) |
| KR (1) | KR20150068956A (zh) |
| CN (1) | CN104755478B (zh) |
| BR (1) | BR112015007214A8 (zh) |
| CA (1) | CA2884766A1 (zh) |
| HK (1) | HK1211574A1 (zh) |
| MX (1) | MX2015004615A (zh) |
| RU (1) | RU2015114936A (zh) |
| WO (1) | WO2014060395A1 (zh) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2909206A1 (en) | 2012-10-16 | 2015-08-26 | F. Hoffmann-La Roche AG | Serine/threonine kinase inhibitors |
| US9532987B2 (en) | 2013-09-05 | 2017-01-03 | Genentech, Inc. | Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases |
| KR102359759B1 (ko) | 2013-12-06 | 2022-02-09 | 제넨테크, 인크. | 세린/트레오닌 키나제 저해제 |
| EP3170822A1 (en) | 2015-11-18 | 2017-05-24 | AGV Discovery | Azaindole derivatives and their use as erk kinase inhibitors |
| CN106749268B (zh) * | 2015-11-24 | 2020-10-09 | 广东东阳光药业有限公司 | 杂芳化合物及其在药物中的应用 |
| MX2018012471A (es) | 2016-04-15 | 2019-02-21 | Genentech Inc | Metodos de diagnostico y terapeuticos para el cancer. |
| KR20200041387A (ko) | 2017-09-08 | 2020-04-21 | 에프. 호프만-라 로슈 아게 | 암의 진단 및 치료 방법 |
| EP3728228A1 (en) | 2017-12-22 | 2020-10-28 | Ravenna Pharmaceuticals, Inc. | Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors |
| WO2019158579A1 (en) | 2018-02-13 | 2019-08-22 | Vib Vzw | Targeting minimal residual disease in cancer with rxr antagonists |
| WO2020102686A1 (en) * | 2018-11-16 | 2020-05-22 | California Institute Of Technology | Erk inhibitors and uses thereof |
| AU2020257301A1 (en) | 2019-04-18 | 2021-11-11 | The Johns Hopkins University | Substituted 2-amino-pyrazolyl-(1,2,4)triazolo(1,5a) pyridine derivatives and use thereof |
| TW202112767A (zh) | 2019-06-17 | 2021-04-01 | 美商佩特拉製藥公司 | 作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物 |
| CN114685490A (zh) * | 2020-12-31 | 2022-07-01 | 江苏先声药业有限公司 | 吡咯并吡啶类化合物及其应用 |
| EP4212531A1 (en) | 2022-01-14 | 2023-07-19 | AGV Discovery | Azaindole derivatives and their use as erk kinase inhibitors |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7049312B1 (en) * | 1999-06-03 | 2006-05-23 | Abbott Gmbh & Co. Kg | Benzothiazinone and benzoxazinone compounds |
| EP2239262A3 (en) * | 2004-07-27 | 2011-10-19 | SGX Pharmaceuticals, Inc. | Fused ring heterocycle kinase modulators |
| EP2316835A1 (en) * | 2004-11-22 | 2011-05-04 | Vertex Pharmceuticals Incorporated | Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
| US8110576B2 (en) * | 2008-06-10 | 2012-02-07 | Plexxikon Inc. | Substituted pyrrolo[2,3b]pyrazines and methods for treatment of raf protein kinase-mediated indications |
| CA2731451A1 (en) * | 2008-07-23 | 2010-01-28 | Vertex Pharmaceuticals Incorporated | Pyrazolopyridine kinase inhibitors |
| JP5630867B2 (ja) * | 2008-08-05 | 2014-11-26 | 第一三共株式会社 | イミダゾピリジン−２−オン誘導体 |
| GB0814364D0 (en) * | 2008-08-05 | 2008-09-10 | Eisai London Res Lab Ltd | Diazaindole derivatives and their use in the inhibition of c-Jun N-terminal kinase |
| MX2012000711A (es) * | 2009-07-15 | 2012-03-16 | Abbott Lab | Inhibidores de pirrolopirazina de cinasas. |
| DE102009060175A1 (de) * | 2009-12-23 | 2011-06-30 | Merck Patent GmbH, 64293 | Pyrrolo[2,3-d] pyrazin-7-yl-pyrimidin-Verbindungen |
| NZ603644A (en) * | 2010-05-24 | 2014-10-31 | Univ Rochester | Bicyclic heteroaryl kinase inhibitors and methods of use |
| CA2803802A1 (en) * | 2010-06-23 | 2011-12-29 | Vertex Pharmaceuticals Incorporated | Pyrrolo- pyrazine derivatives useful as inhibitors of atr kinase |
| DE102010049877A1 (de) * | 2010-11-01 | 2012-05-03 | Merck Patent Gmbh | 7-((1,2,3)Triazol-4-yl)-pyrrolo(2,3) pyrazinderivate |
| WO2012118850A1 (en) | 2011-02-28 | 2012-09-07 | Array Biopharma Inc. | Serine/threonine kinase inhibitors |
| CN103958502B (zh) | 2011-08-04 | 2016-02-10 | 阵列生物制药公司 | 作为丝氨酸/苏氨酸激酶抑制剂的喹唑啉化合物 |
| PL3321262T3 (pl) | 2012-03-01 | 2021-06-28 | Array Biopharma, Inc. | Inhibitory kinaz serynowo/treoninowych |
| WO2014036015A1 (en) | 2012-08-27 | 2014-03-06 | Array Biopharma Inc. | Serine/threonine kinase inhibitors for the treatment of hyperproliferative|diseases |
| EP2909206A1 (en) | 2012-10-16 | 2015-08-26 | F. Hoffmann-La Roche AG | Serine/threonine kinase inhibitors |
| KR102359759B1 (ko) | 2013-12-06 | 2022-02-09 | 제넨테크, 인크. | 세린/트레오닌 키나제 저해제 |
| CN105848723B (zh) | 2013-12-30 | 2019-08-02 | 基因泰克公司 | 丝氨酸/苏氨酸激酶抑制剂 |
| JP6642942B2 (ja) | 2013-12-30 | 2020-02-12 | アレイ バイオファーマ、インコーポレイテッド | セリン／トレオニンキナーゼ阻害剤 |
-
2013
- 2013-10-15 EP EP13776509.5A patent/EP2909206A1/en not_active Withdrawn
- 2013-10-15 KR KR1020157009259A patent/KR20150068956A/ko not_active Application Discontinuation
- 2013-10-15 RU RU2015114936A patent/RU2015114936A/ru not_active Application Discontinuation
- 2013-10-15 CN CN201380053604.6A patent/CN104755478B/zh not_active Expired - Fee Related
- 2013-10-15 WO PCT/EP2013/071496 patent/WO2014060395A1/en active Application Filing
- 2013-10-15 BR BR112015007214A patent/BR112015007214A8/pt not_active Application Discontinuation
- 2013-10-15 JP JP2015536185A patent/JP2015533151A/ja active Pending
- 2013-10-15 MX MX2015004615A patent/MX2015004615A/es unknown
- 2013-10-15 CA CA2884766A patent/CA2884766A1/en not_active Abandoned
-
2015
- 2015-04-16 US US14/688,724 patent/US9382257B2/en not_active Expired - Fee Related
- 2015-12-11 HK HK15112240.6A patent/HK1211574A1/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20150218176A1 (en) | 2015-08-06 |
| RU2015114936A (ru) | 2016-12-10 |
| WO2014060395A1 (en) | 2014-04-24 |
| CN104755478B (zh) | 2017-10-10 |
| EP2909206A1 (en) | 2015-08-26 |
| CA2884766A1 (en) | 2014-04-24 |
| MX2015004615A (es) | 2015-07-17 |
| US9382257B2 (en) | 2016-07-05 |
| BR112015007214A8 (pt) | 2018-02-06 |
| KR20150068956A (ko) | 2015-06-22 |
| JP2015533151A (ja) | 2015-11-19 |
| CN104755478A (zh) | 2015-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1254429A1 (zh) | 絲氨酸/蘇氨酸激酶抑制劑 | |
| IL261282A (en) | Furinone compounds as kinase inhibitors | |
| HK1225735A1 (zh) | 絲氨酸/蘇氨酸激酶抑制劑 | |
| HK1210775A1 (zh) | 作為激酶抑制劑的咪唑並三嗪甲腈 | |
| HK1208442A1 (zh) | 作為 激酶抑制劑的取代的吡咯並嘧啶基氨基－苯並噻唑酮 | |
| HK1223877A1 (zh) | 絲氨酸/蘇氨酸激酶抑制劑 | |
| HK1211574A1 (zh) | 絲氨酸/蘇氨酸激酶抑制劑 | |
| HK1210174A1 (zh) | 用於治療過度增殖性|疾病的絲氨酸/蘇氨酸激酶抑制劑 | |
| HK1222647A1 (zh) | 激酶抑制劑 | |
| IL227399A0 (en) | Novel azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors | |
| EP2710007A4 (en) | Kinase Inhibitors | |
| HK1211578A1 (zh) | 作為 激酶抑制劑的酰氨基咪唑並噠嗪 | |
| GB201211310D0 (en) | CSF-1R kinase inhibitors | |
| HK1213252A1 (zh) | 雙環二氫吡啶酮激酶抑制劑 | |
| EP2702064A4 (en) | Kinase Inhibitors | |
| ZA201604461B (en) | Serine/threonine kinase inhibitors | |
| PL2634185T3 (pl) | Inhibitory kinazy TYK2 | |
| HK1199873A1 (zh) | 激酶抑制劑 | |
| SG11201500973WA (en) | Amino-quinolines as kinase inhibitors | |
| HK1213181A1 (zh) | 雙環氧雜內酰胺激酶抑制劑 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20211021 |